Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Wockhardt Limited manufactures and markets pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines.
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
1 day ago•Bloomberg Quint
1 day ago•Moneycontrol
1 week ago•Bloomberg Quint
Wockhardt Limited has informed the Exchange regarding allotment of 9285163 securities pursuant to Qualified Institution Placement at its meeting held on March 26, 2024. | Download
Wockhardt Limited has informed the Exchange regarding allotment of 9285163 securities pursuant to Qualified Institution Placement at its meeting held on March 26, 2024. | Download
Interim • Div/Share: ₹ 10
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 3.47%